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Abstract
Airway inflammation plays a major role in the pathogenesis of influenza viruses and can lead to a fatal outcome. One of the
challenging objectives in the field of influenza research is the identification of the molecular bases associated to the
immunopathological disorders developed during infection. While its precise function in the virus cycle is still unclear, the
viral protein PB1-F2 is proposed to exert a deleterious activity within the infected host. Using an engineered recombinant
virus unable to express PB1-F2 and its wild-type homolog, we analyzed and compared the pathogenicity and host response
developed by the two viruses in a mouse model. We confirmed that the deletion of PB1-F2 renders the virus less virulent.
The global transcriptomic analyses of the infected lungs revealed a potent impact of PB1-F2 on the response developed by
the host. Thus, after two days post-infection, PB1-F2 invalidation severely decreased the number of genes activated by the
host. PB1-F2 expression induced an increase in the number and level of expression of activated genes linked to cell death,
inflammatory response and neutrophil chemotaxis. When generating interactive gene networks specific to PB1-F2, we
identified IFN-c as a central regulator of PB1-F2-regulated genes. The enhanced cell death of airway-recruited leukocytes
was evidenced using an apoptosis assay, confirming the pro-apoptotic properties of PB1-F2. Using a NF-kB luciferase
adenoviral vector, we were able to quantify in vivo the implication of NF-kB in the inflammation mediated by the influenza
virus infection; we found that PB1-F2 expression intensifies the NF-kB activity. Finally, we quantified the neutrophil
recruitment within the airways, and showed that this type of leukocyte is more abundant during the infection of the wild-
type virus. Collectively, these data demonstrate that PB1-F2 strongly influences the early host response during IAV infection
and provides new insights into the mechanisms by which PB1-F2 mediates virulence.
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Introduction
Influenza A virus (IAV) commonly causes acute respiratory
infection and is one of the most important human pathogens,
causing between 250,000 and 500,000 deaths every year around
the world [1]. IAV are enveloped viruses belonging to the
Orthomyxoviridae family. Their negative strand RNA genome is
composed of 8 segments encoding up to 12 proteins. PB1-F2 is a
virulence factor first described 10 years ago [2]. This 75–90 amino
acid long accessory protein is encoded by an alternative +1 reading
frame on segment 2 which also encodes the RNA polymerase basic
protein 1 (PB1) and N40, an N-terminally truncated version of
PB1 lacking transcriptase function [2,3]. PB1-F2 is expressed by
most IAV strains and has been shown to be associated with
immunopathological processes observed during infection [4,5,6].
During IAV infection, production of pro-inflammatory cytokines
generally results in an innate host response that controls the virus
propagation until it is eliminated by the adaptive immune system.
However, in some cases, excessive host inflammatory response
contributes to disease severity, especially with highly pathogenic
strains such as avian H5N1 or the 1918 pandemic H1N1 strain
(‘‘Spanish flu’’) [7,8]. PB1-F2 is suspected to contribute to this
disproportional response which frequently leads to vital respiratory
tissue damage and death of the infected person [5].
Several in vivo studies allowed determining the pathophysiolog-
ical consequences of PB1-F2 expression during IAV infection.
Using an attenuated model of mouse infection, Zamarin et al.
demonstrated that wild type (wt) IAV displays a higher patho-
genicity than its PB1-F2 knockout counterpart [9]. A single N66S
mutation present in the PB1-F2 of the 1918 pandemic strain is
sufficient to transform a strain of moderate virulence into a highly
pathogenic virus in mice [10]. More recently, a study analyzing
the effects of PB1-F2 in the IAV-induced pathogenesis of avian
hosts also revealed that amino acid changes within the PB1-F2
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in ducks [11]. PB1-F2 was also described as facilitating secondary
infection with Streptococcus pneumoniae [12]. In contrast, when
introducing a functional PB1-F2 in the 2009 pandemic H1N1 IAV
that does not encode this accessory protein, only minimal immune
response modulation was observed, underlying the complex
contribution of PB1-F2 in virulence [13].
We recently showed that PB1-F2 exacerbates IFN-b production
through the activation of the NF-kB pathway during IAV infection
of the human respiratory epithelial cell line A549, but not during
infection of immune cells [6]. Despite its apoptotic functions,
pathways related to cell death were not activated differently in wt
and PB1-F2 knockout virus-infected A549 cells. In the present
study, we analyzed the global transcriptional response of the mouse
respiratory tract associated to PB1-F2 during IAV infection. We
report that PB1-F2 expression during IAV infection increases the
inflammatory response of the host. PB1-F2 plays a major role in
NF-kB pathway activation, chemotaxis of granulocyte and apopto-
sis of recruited immune cells. Furthermore, we determined that
IFN-c expression is enhanced when PB1-F2 is expressed, and
appears to have a central position in the gene network responsible
for the respiratory disease provoked by IAV.
Results
Kinetics of PB1-F2 protein expression in infected mice
and associated-pathogenicity
In order to analyze the impact of PB1-F2 expression in
pathogenicity, we first examined the kinetics of PB1-F2 expression
in a mouse infection model using the mouse-adapted A/WSN/
1933 (H1N1) strain of IAV. The time course of PB1-F2 expression
in the lungs of infected mice was analyzed. PB1-F2 was efficiently
expressed at day 2 post-infection (pi) and expression increased at
day 3 and 4 pi (Fig. 1A). Densitometric measurement of PB1-F2
levels standardized to b-actin levels on distinct infected mice
confirmed the increase of PB1-F2 expression at days 3 and 4 pi
(Fig. S1). Using a sensorchip assay (Biacore) with an anti-PB1-F2
monoclonal antibody [14], the PB1-F2 concentration was
estimated to range around 4 pmol per 100 pmol of NP at day
4 pi, corresponding to 26 pmol of PB1-F2 per mg of infected lung
tissue.
We then aimed to determine the specific effect of PB1-F2
expression on the mouse mortality rate using the wt virus and a
mutant knocked-out for PB1-F2 expression. To this end, and
because the introduction of mutations at the initiation and internal
AUG codons of the PB1-F2 open reading frame (ORF) may result
in the generation of truncated PB1 products [2,3], we generated
mutants unable to reinitiate translation in the two ORFs: PB1-F2-
null and N40-null mutants (Fig. S2A). We then compared the
effect of PB1-F2- and N40-null mutations on PB1 expression in the
infected mouse epithelial cell line MLE15 in order to verify that all
viruses expressed similar amounts of PB1 (Fig. S2B). Furthermore,
to determine if N40 expression may modify the host immune
response, infections of MLE15 cells by the wt virus and its mutants
were carried out and IFN-b synthesis induction analyzed. As
expected, the N40 null-mutants induced similar amounts of IFN-b
than the wt virus, allowing us to exclude the involvement of N40 in
host-response exacerbation processes (Fig. S2C). Therefore, we
retained the fully knocked-out mutant DF2 for further mice
infections and subsequent analyses [6].
While 100% mortality was reached when mice were inoculated
with 1610
6 PFU with the wt and the DF2 viruses, the 50% Lethal
Doses (LD50) were estimated to be 1.48610
5 PFU [95% con-
fidence interval (CI), 0.97610
5 - 1.9610
5] with the wt virus and
2.81610
5 PFU [CI, 2.6610
5 - 2.99610
5] with the DF2 virus. No
mortality was observed when mice were inoculated with
Figure 1. Expression of PB1-F2 and associated pathogenicity in
infected mice. (A) In vivo kinetics of PB1-F2 expression in IAV-infected
mice lungs. C57Bl/6 mice were infected with 1.5610
5 PFU of IAV strain
A/WSN/33. Lungs were collected at different time points pi and lysates
were subjected to Western blot using antisera against PB1-F2 and NS1.
b-actin was used as a loading control. (B) Lethality induced by wt and
DF2 IAV in C57Bl/6 mice. Mice received intranasally 2.5610
5 PFU of wt
or DF2 IAV and were observed daily for signs of morbidity.
doi:10.1371/journal.ppat.1002202.g001
Author Summary
Influenza A viruses may cause severe respiratory disease.
PB1-F2, a viral protein identified in 2001 is suspected to
play a role in influenza-related pneumonia. In order to
understand the impact of PB1-F2 in the pathogenesis
underlying Influenza A virus infection, we engineered a
mutant virus unable to express PB1-F2. By the use of high-
throughput gene expression assays, we compared the host
responses of the wild-type-infected and the PB1-F2
mutant-infected mice. We identified that PB1-F2 expres-
sion enhances the immune cell death and inflammatory
responses of mice. The inflammatory response mediated
by the PB1-F2 expression leads to a massive recruitment of
leukocytes within the air spaces, a feature that character-
izes the influenza-mediated immunopathology. Our results
suggest that PB1-F2 is a virulence factor implicated in the
deregulation of the inflammatory response observed in
acute influenza virus pneumonia. These data underlie the
complexities of virus-host interactions and help us
understand by which mechanisms Influenza viruses
mediate severe respiratory diseases.
PB1-F2 Increases Inflammatory Host-Response
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4 PFU of the two viruses. A survival curve after a viral
challenge using 2.5610
5 PFU is shown in Fig.1B. A lower mortality
rate was observed in the DF2 infected mice when compared to the
wt infected mice (40% vs. 80%). Immunohisto-labelling of NS1 in
mouse-infected lungs showed equivalent signal intensities for the
two viruses indicating an identical viral infectivity (Fig. S3). These
data are indicative of an impact of PB1-F2 expression in IAV-
induced pathogenicity.
PB1-F2 causes increased morbidity and enhanced IFN-b
expression
To investigate the contribution of PB1-F2 in virus pathogenic-
ity, we infected groups of mice at high and low infectious doses to
measure and compare morbidities, replication levels and IFN-b
inductions. Measurement of IFN-b was carried out since we
previously observed that PB1-F2 exacerbates IFN-b expression
within in vitro infected human pulmonary cells [6]. In response to a
high viral challenge (1610
6 PFU), the two groups of mice (wt- and
DF2-infected mice) were as sensitive (0% survival for both groups)
and lost the same weight (Fig. 2A). When infections were carried
out with lower sub-lethal doses of virus (5610
4 PFU), wt-infected
mice lost a greater percentage of body weight than their DF2-
infected counterparts: 29% vs. 14% at day 6 pi (Fig. 2B). The
differential weight loss persisted during the viral infection. To
determine whether the morbidity associated to PB1-F2 expression
could be attributed to a reduced viral replication in DF2 infected
mice, we assessed viral RNA in the lungs by qRT-PCR. As shown
in Fig. 2C and 2D, at day 3 pi, both viruses replicate with the
same efficiencies when mice were infected with a high or a low
viral dose. Wt- and DF2-virus titers were also identical at days 2
and 4 pi (data not shown). These observations are consistent with
previous studies [6,9]. We then measured the level of induction of
IFN-b gene transcription at day 3 pi in the two conditions of viral
challenge. When mice were infected with 1610
6 PFU, both viral
infections induced a strong IFN-b expression with the same range
of magnitude (Fig. 2E). At the lower infection dose, while IFN-b
gene transcription is still strongly induced in wt-infected mice, a
reduced fold of induction was observed in DF2-infected mice
(Fig. 2F). Collectively our results indicate that, as we previously
observed in cultured human epithelial pulmonary cells, PB1-F2 is
able to exacerbate IFN-b expression in infected mice.
Comparison of the mouse lung response to wt and DF2
IAV mutant
To provide additional insights on the pathogenicity associated
to PB1-F2 expression during IAV infection, we investigated tran-
scriptional profiles of the host genes in the lungs of mice infected
by the wt- and the DF2-virus by microarray analyses. Mice were
infected intranasally with 1.5610
5 PFU and total RNA were
extracted from mice lungs at day 2, 3, and 4 pi and analyzed by
microarrays containing more than 44,000 oligonucleotides repre-
sentative of the whole murine transcriptome. The transcriptomic
profiles obtained at day 2 pi showed the most relevant differences
between the two infection conditions. A Venn diagram shown in
Fig. 3A summarizes the differentially expressed genes common or
unique to wt and DF2 virus infections at day 2 pi. A total of 6025
genes showed a greater-than-2-fold up- or down-regulation in wt-
infected lungs relative to mock-infected lung (p,0.05). By contrast,
when looking at the regulated-genes during the infection with the
DF2 virus, only 937 genes were regulated, demonstrating that
PB1-F2 severely influence the early host response during IAV
infection of mice. The most significant canonical pathways spe-
cifically associated with wt and DF2 virus infections according to
Ingenuity Pathway Analysis (IPA) software are listed in Fig. 3B.
The analysis revealed that both viruses induced genes involved in
‘‘Respiratory disease’’ showing that wt and DF2 viruses are both
able to establish a deleterious infection in C57Bl/6 mice. Genes
involved in the ‘‘Cell death’’ pathway are expressed at high levels
in mice infected by the wt virus while it is not statistically regulated
in DF2-infected mice. This is consistent with the fact that PB1-F2
is described as a proapoptotic factor in immune cells [2]. Another
main functional consequence of the PB1-F2 deletion observed is
the drastically reduced inflammatory response developed during
the DF2 virus infection. This suggests a potent pro-inflammatory
activity of PB1-F2 that could be an important contributor to severe
immunopathology associated with highly pathogenic IAV strains.
We also observed a correlation between PB1-F2 expression and
the pathways ‘‘Tissue Morphology’’ and ‘‘Hematological System
Development and Function’’, which are direct consequences of the
inflammatory response. As shown in Fig.3C, genes implicated in
inflammatory processes were shown to be preferentially regulated
during the wt IAV infection, including genes involved in chemo-
taxis and activation of granulocytes (Cxcl2, Cxcl3, Csf3, Trem1),
genes encoding acute-phase proteins (Saa1, Saa3 and Saa4) and
multiple other genes implicated in defense response. In order to
validate the microarray expression data, we assayed several genes
presented in Fig. 3C by qRT-PCR (Ccr1, Cxcl1, Csf3, Ptx3, Tnf-a
and Trem1). These experiments performed on independent mice
confirmed the PB1-F2 effect on inflammatory genes (Fig. S4).
Collectively, these results suggest that PB1-F2 amplifies the
inflammation observed during IAV infection, a feature that was
partially identified in our previous analysis using the A549 cell
infection model.
PB1-F2 expression induces an increase in inflammatory
mediator secretions during IAV infection
To further explore the host responses associated with PB1-F2
expression, we characterized the functional relationship between
genes that were induced or inhibited more than two fold (p,0.05)
between wt- and DF2-infected mice. Fig. 4A shows a represen-
tation of the significant gene network associated with PB1-F2
expression during mice infection. Top functions associated with
this gene network were related to immune cell trafficking, inflam-
matory response and cell death. Of particular interest is the central
position of IFN-c in this network. IFN-c is linked to multiple genes
including peptidases, apoptotic activators, chemokines and cyto-
kines. Most of these genes are involved in immune cell functions or
in recruitment of monocytes and granulocytes towards sites of
tissue infection.
To confirm the ability of PB1-F2 to promote an increase in
inflammatory mediator secretion during infection, we dosed by
ELISA the amount of several cytokines involved in the
inflammation process in the bronchoalveolar lavage (BAL) fluid
of infected animals. Thus, IFNc was quantified due to its central
position within the network, TNFa because of its potent role in
inflammatory processes, CXCL1/KC for its important role in
neutrophil chemoattraction and IL6 as the most important
mediator of fever and for its role in the acute phase response. As
shown in Fig. 4B, these four cytokines were present in lower
amounts in the BAL of mice infected by the DF2 virus when
compared with BAL obtained from animals infected with the wt
virus. These statistically relevant observations further confirmed
the pro-inflammatory capacities of PB1-F2 during IAV infection.
Altogether, our results indicate that upon influenza infection,
the respiratory tract exhibits increased lysosomal proteases,
leucocyte chemoattractants, and inflammatory signaling mRNA
transcripts when PB1-F2 is expressed and suggest that this viral
PB1-F2 Increases Inflammatory Host-Response
PLoS Pathogens | www.plospathogens.org 3 August 2011 | Volume 7 | Issue 8 | e1002202Figure 2. Effect of PB1-F2 expression on pathogenicity during IAV infection. (A-B) Time-course of body weight changes, mice were
inoculated with 1610
6 PFU (A) and 5610
4 PFU (B) and their weights measured every day. (C-D) Viral load in lungs of mice challenged by 1610
6 PFU
(C) and 5610
4 PFU (D) of wt and DF2 IAV. Results are the mean 6 SD values obtained from 4 animals at day 3 pi. They are expressed as RNA copies
normalized to the quantity of RNA used in the experiment. (E–F) Real time RT-PCR quantification of IFN-b gene expression in lungs of mice infected
by 1610
6 PFU (E) and 5610
4 PFU (F) of wt and DF2 IAV 3 days pi. IFN-b expression was normalized with the b-actin gene expression level and
presented as fold increase relative to mock-treated mice. (* p,0.05; **p,0.01).
doi:10.1371/journal.ppat.1002202.g002
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PLoS Pathogens | www.plospathogens.org 4 August 2011 | Volume 7 | Issue 8 | e1002202Figure 3. Microarray analysis of gene expression in the lungs of mice on day 2 pi. (A) Venn diagram showing the distribution of
differentially regulated genes during infection with wt or DF2 IAV relative to mock-infected mice. (B) Functional categories comparison of
differentially expressed genes in lungs of mice infected with wt or DF2 IAV. (C) Heat map of selected genes related to innate defense in the lungs of
wt- and DF2-infected mice at day 2 pi based on analysis using Genespring software (Agilent). Genes shown in red are up-regulated and those shown
in blue are down-regulated in infected mice compared to mock-infected mice. Data are expressed in Log base 2 ratio.
doi:10.1371/journal.ppat.1002202.g003
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and might be involved in severe immunopathology.
Apoptosis of BAL immune cells is mediated by PB1-F2
We sought to verify the microarray results by assessing apoptosis
in cells found in BAL fluids. BAL total cells were harvested at day
3 pi and the apoptotic index monitored. We opted for a method
allowing the distinction between necrosis and apoptosis, and giving
a result in the form of a ratio, excluding differences in terms of
number of cells. As shown in Fig. 5A, the apoptotic index of cells
recruited in the airways of wt-infected mice is significantly
increased when compared to the mock-infected mice. Conversely,
when apoptosis quantification was made in DF2-infected mice, we
found that the apoptosis index was significantly reduced when
compared to wt-infected mice. We next used the IPA software to
identify the apoptosis-related signalling pathways activated during
wt IAV infection of mice lungs. As shown in Fig.5B, multiple genes
involved in the pathway linked to TNF/FasL-mediated apoptosis
are induced (red) when mice were infected with the wt virus,
including numerous caspases. Apoptotic genes induced under
these conditions suggest that the PB1-F2-mediated apoptosis
response of the infected lung is mediated by activation of genes
promoting cell shrinkage and membrane blebbing.
PB1-F2 expression mediates an exacerbation of NF-kB
activation during infection
NF-kB is the major pro-inflammatory transcriptional factor and
regulates the induction of most proinflammatory cytokines. We
recently observed that PB1-F2 mediates an upregulation of IFN-b
by NF-kB activation in human pulmonary cells [6]. We thus
Figure 4. Gene network analysis. (A) Biological network of genes that were specifically regulated more than 2 fold (P,0.05) in the wt-infected
mice lungs compared with mock-infected controls. Lines between nodes in the network represent gene interactions. Subset of genes that were
regulated during wt IAV infection but not during DF2 IAV infection are shown in red, and genes expressed at a high level in the two infectious
conditions are shown in blue. Biological networks were made by using Ingenuity Pathway Analysis. The meaning of the symbols is indicated in the
inset of the figure. (B) BAL fluids levels of IFN-c, TNF-a, CXCL1/KC and IL-6 in mock-infected, wt-infected and DF2-infected mice at day 2 (IFN-c) or day
3 (TNF-a, CXCL1/KC and IL-6) pi (*p,0.05, **p,0.01).
doi:10.1371/journal.ppat.1002202.g004
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during an in vivo IAV infection. We used an adenovirus containing
an NF-kB response element linked to a luciferase reporter gene
(Ad-NF-kB-luc) [15]. As a positive control, we showed that E. Coli
LPS induces NF-kB activation (Fig. S5). Control mice infected
with Ad-NF-kB-luc alone (PBS) showed no NF-kB activity,
attesting that the vector has no inflammatory activity by itself.
Mice were co-infected with the Ad-NF-kB-luc and either the wt
IAV or the DF2 IAV (1.5610
5 PFU per mouse). Mice were then
followed daily for luciferase activity measurement (Fig. 6A). Wt-
infected mice developed an important inflammatory reaction with
a peak of activity after 3 days pi in contrast to animals infected by
the DF2 virus that developed a moderate NF-kB activity (Fig. 6B).
Quantification of the luciferase activity showed that the difference
is observable at day 3 pi, which corresponds to the viral replication
peak (data not shown).
Differential immune cell recruitment between wt- and
DF2-infected mice
To determine whether PB1-F2 expression could be responsible
for an increased recruitment of granulocytes during IAV infec-
tion, as suggested by the microarray data, we assessed cellular
infiltration in the air spaces. Leukocytes were harvested from the
BAL of mock-, wt- and DF2-infected mice 3 days pi, the number
and phenotype of the cells were characterized by cytospin slide
counting. Analysis of the BAL leukocyte populations demonstrated
that IAV infections induced the accumulation of polynuclear
neutrophils (PNN) in the airways. PNN constitute more than 80 %
of the cells found in the BAL fluid of infected mice. The PNN
accumulation peaked at day 3 pi and decreased thereafter (Fig.7A).
When compared to DF2-infected mice, wt-infected mice PNN
counts revealed a significantly more important afflux of PNN at
day 3 pi (Fig.7A). To further investigate the PB1-F2 effect in the
lung tissue, we quantified the myeloperoxidase (MPO, a lysosomal
protein specific for PNN) signal at day 3 pi by immunohistology.
Infected lung sections presented characteristic histological aspects
related to acute inflammation. Staining of the viral NS1 protein
showed a characteristic bronchial localization that was homoge-
nous and equivalent in intensity for the two viruses (Fig.7C).
Immunohistochemical localization of MPO showed an intense
signal in bronchial tissue when mice were infected with the wt
virus at day 3 pi. However, when DF2-infected mice were
analyzed, a weaker MPO signal was observed in the bronchial
tissue (Fig.7B, 7C) highlighting the potent pro-inflammatory effect
Figure 5. Apoptotic index of leukocytes present in the BAL fluids of IAV-infected mice. (A) Cells from BAL fluids of IAV-infected mice were
harvested after 3 days pi. Apoptotic index was assayed by measuring the ADP:ATP ratio (*p,0.05). (B) Ingenuity Systems software was used to
represent regulation of genes involved in apoptotic pathway during wt IAV infection of mice lungs. Genes depicted in red are increased and genes in
green are decreased compared with mock-infected mice. Color intensity increases with the magnitude of fold-change.
doi:10.1371/journal.ppat.1002202.g005
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analyses designate PB1-F2 as a virulence factor playing a harmful
role in the pathogenesis of IAV infection.
Discussion
Innate immune response is considered as an essential process
required for efficient pathogen clearance. However, deregulation
of this response can lead to severe damage for the host. The
regulation of host defenses to IAV infections is particularly com-
plex and leukocyte recruitment to the inflammatory lung, which is
beneficial for clearing the virus, can become deleterious to the host
tissues if the reaction is excessive [16]. In fact, although inflam-
mation is essential for IAV clearance, it is becoming increasingly
evident that a tight regulation of this process is necessary to avoid
development of IAV-related immunopathological sequelae [8,17].
It illustrates the ambiguity of the host response to infections. The
strength of the response has to be proportionate to the pathogen
attack in order to eliminate it. If the response is too weak, the
pathogen will proliferate, leading to infection. If the host response
is too strong, uncontrolled inflammatory reaction will lead to tissue
destruction.
The present study demonstrates that PB1-F2 is endowed with
pro-inflammatory activity and plays a role in the immunopatho-
logical consequences observed in severe impairment of influenza-
infected lung function. By the use of reverse genetics, we obtained
a mutant virus unable to express PB1-F2 and showed that this
mutant was less lethal and virulent than the wt virus, consistent
with a previous study [9]. These differences cannot be explained
by reduced replication efficiency of the DF2 virus since no
replication variation was observed between the two viruses.
Besides, the use of mutants deleted for N40 or PB1-F2 exclude a
potential role of N40 in this process.
Our previous study identified IFN-b gene as a PB1-F2-mediated
exacerbated gene during IAV infection of a human respiratory
epithelial cell line [6]. Based on these previous results, we
hypothesized that PB1-F2 expression may stimulate in vivo the
host immune response, and as a consequence, be a key element
that could explain the higher virulence of a virus expressing PB1-
F2. IFN-b measurement within infected-mice lungs confirmed our
preliminary in vitro observation. To further study whether PB1-F2
could cause immunopathology, we compared the global gene
expression patterns of wt- and DF2-infected mouse lungs. Our
data demonstrate that expression of PB1-F2 during IAV infection
enhances the host defense responses by strongly increasing the
transcriptional profile of genes involved in inflammation, granu-
locyte migration and apoptotic pathways. No apoptotic pathways
were identified when these two viruses were used to infect human
pulmonary epithelial cells in vitro [6]. This may reflect the cell-
specific behavior of PB1-F2 that only induces apoptotic process
within immune cells and not in epithelial cells [2]. Thus, the use of
the wt/DF2 virus couple showed the ability of PB1-F2 to modulate
the host response, contributing to virulence in vivo. This is
supported by a recent work by McAuley et al. characterizing the
immunomodulatory properties of several variants of the PB1-F2
protein [5].
Using IPA software, we were able to analyze the functional
relationships between the genes differentially regulated when PB1-
F2 was expressed or not during infection. The analysis revealed
the central role of IFN-c, which could act as a relay between
Figure 6. NF-kB luminescence in the lungs of wt and DF2 IAV-infected mice. (A) Groups of 4 Balb/c mice were co-infected at day 0 by either
wt or DF2 IAV (1.5610
5 PFU per mouse) and by a replication-deficient adenovirus used to transduce NF-kB-luciferase construct (Ad-NF-kB-luc).
Bioluminescence was then measured daily by intranasal injection of 50 ml of luciferine (500 mg/ml) and capture of photon emission from the chest at
different times post-infection using the IVIS system. (B) Pictures of anesthetized mice after luciferine instillation taken 3 days pi. The scale on the right
indicates the average radiance: the sum of the photons per second from each pixel inside the ROI/number of pixels (photons/sec/cm
2/sr).
doi:10.1371/journal.ppat.1002202.g006
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PLoS Pathogens | www.plospathogens.org 8 August 2011 | Volume 7 | Issue 8 | e1002202Figure 7. PB1-F2 promotes neutrophil recruitment within IAV-infected mice lungs. (A) Groups of three mice were infected by the wt or the
DF2virusesandassayedfornumberofneutrophilsintheBAL fluidsafter0,2,3and4dayspi.(B)Insituimmunohistochemistry labelingoftheneutrophil
marker MPO was assayed on wt-infected and DF2-infected 3 days pi. MPO signal density was quantified using ‘‘Image J’’ software. (C) Representative
sections of mock-infected (left panels), wt-infected (middle panels) and DF2-infected (right panels) mice lungs labeled for NS1 and MPO.
doi:10.1371/journal.ppat.1002202.g007
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matory response, immune cell trafficking, tissue remodeling and
apoptosis induction. The PB1-F2-specific increase of IFN-c
expression was confirmed at the protein level in BAL fluids of
infected mice. IFN-c is a member of the type II interferon family
and is a potent activator of macrophages and neutrophils. It is
worth noting that in the IAV-infected pulmonary environment,
IFN-c represses the innate immunity developed by alveolar
macrophages to enhance their adaptive antiviral response through
increased MHC gene expression [18]. Consequently, the scaven-
ger receptor MARCO is down-regulated, and innate defense
against secondary bacterial infections is suppressed. The link that
we identified between PB1-F2 and IFN-c over-expression appears
of first importance since PB1-F2 has been previously described as
facilitating the development of opportunistic pneumococcal and
staphylococcal infections [12,19]. Collectively, our data provide
a rationale to understand how PB1-F2 exacerbate secondary
bacterial infections and post-influenza pneumonia: PB1-F2 induces
an apoptosis increase of recruited leucocytes together with a switch
of their activation state from innate immunity to adaptive antiviral
response through an exacerbation of the IFN-c expression in the
lung.
The mechanism by which PB1-F2 mediates inflammatory
increase by itself is still unknown. However, NF-kB pathway
exacerbation is involved in this process as shown by the dramatic
decrease of NF-kB activity in lungs of mice infected by the DF2
virus when compared to the wt infection (Fig. 6). The targeting of
PB1-F2 to mitochondria could explain the NF-kB pathway
exacerbation through a membrane destabilization of this organelle
and activation of the RIG-I/MAVS signaling pathway. However
PB1-F2 mitochondrial localization is a matter of debate since
several studies described differential localization depending on the
strain of the virus and the sequence polymorphism of the protein
[20,21]. The capability of PB1-F2 to perforate or target other
cellular membranes could also explain its inflammatory and
apoptotic activities [14,22,23]. Considering the membrane affinity
of PB1-F2, it could form protein pores in endoplasmic reticulum
and subsequently induce the release of Ca
2+ within the cytosol.
Such increase in concentration of Ca
2+ in the cytosol is described
to activate the NF-kB pathway and to play a pivotal role in
inducing proinflammatory gene transcription in airway epithelial
cells [24]. Another important characteristic of PB1-F2 is its
propensity to form or promote the formation of amyloı ¨dic fibers in
infected monocytes [14]. These fibrillar aggregates are believed to
associate to the membrane, disrupt its integrity and lead to
perturbation of the cellular compartmentalization. This suggests
that PB1-F2 could contribute to the pulmonary dysfunctions
observed throughout IAV infections by several pathways.
A striking feature of the inflammation exacerbated by PB1-F2
expression is the enhanced neutrophil recruitment within infected
airways. There is evidence, based on their function, that neutro-
phils play an important role in mediating acute injury character-
istic of highly pathogenic IAV infections. Circulating neutrophils
migrate to the site of infection and participate in the destruction of
pathogens. However this process has to be tightly regulated since
the beneficial effect for eliminating microbes can become delete-
rious to host tissues through the development of lesions. Indeed
neutrophils have the potential to damage airspaces by releasing
serine proteases and by generating reactive oxygen species [25].
Neutrophil recruitment within lung tissue also increases protein
permeability across the endothelial and epithelial barriers of the
lung. This leads to the flooding of alveoli by plasma liquid and
proteins and is characteristic of early lung injury [26]. However,
depletion of neutrophils prior to influenza infection increased viral
load and mortality compared to non-treated mice [27], confirming
the importance of this type of leucocyte during IAV infection, and
underlying the complexity of the host-IAV interactions. A fine
balance between inflammation and immunity is necessary to
eliminate IAV. Our study shows that PB1-F2 is implicated in the
dysfunction of this balance and that it induces a massive
recruitment of neutrophils within airspaces through deregulation
of the innate host defense.
In summary, the present study demonstrated that PB1-F2
expression significantly increases the expression of genes associated
with inflammation in the airways of IAV-infected mice. We
identified IFN-c as a pivotal host component implicated in this
process, orchestrating immune cell apoptosis induction, granulocyte
recruitment and tissue remodeling observed in infected lungs. The
PB1-F2 specific NF-kB pathway exacerbation that we revealed is
probably involved in this IFN-c expression increase. Further studies
are required to correlate PB1-F2 sequence variability and IAV
virulence to help in the prediction of the pathogenicity of emerging
virus strains in the human population.
Materials and Methods
Ethics statement
This study was carried out in accordance with INRA guidelines
in compliance with European animal welfare regulation. The
protocol was approved by the Animal Care and Use Committee at
CRJ under relevant institutional (DSV, permit number: 7827) and
INRA ‘‘Sante ´ Animale’’ department guidelines. All experimental
procedures were performed in a Biosafety level 2 facility.
Generation of recombinant influenza virus
Influenza A/WSN/1933 (H1N1) was used in this study. Wild
type and PB1-F2 knockout viruses were produced using the 12
plasmid reverse genetics system [28]. The viruses were prepared as
previously described [14].
Mice strains
Female C57Bl/6 and Balb/c mice were purchased from the
Centred’Elevage R.Janvier(LeGenestSaint-Isle, France) and were
used around 8 weeks of age. Mice strains were bred in an animal
facility in pathogen-free conditions. Mice were fed normal mouse
chow and water ad libitum and were reared and housed under
standard conditions with air filtration. For infection experiments,
mice were housed in cages inside stainless steel isolation cabinets
that wereventilated undernegativepressurewithHEPA-filteredair.
Animal infection and fluid collection
Mice were anesthetized by a mixture of ketamine and xylazine
(1 and 0.2 mg per mouse, respectively) and infected intranasally
with 50 ml of PBS containing 1610
6,5 610
5, 2.5610
5, 1.5610
5 or
5610
4 plaque forming units (PFU) of IAV. To determine the lethal
dose 50% (LD50), groups of 5 mice were infected with different
dilutions of virus and observed for signs of morbidity and death
over 18 days. Alternatively, mice were killed at different time
points, BAL fluids and lungs were then collected as previously
described [29].
RNA extraction and quantitative RT-PCR analysis
Total RNA isolated from mice lungs using Qiagen Rneasy kit
(Qiagen) was treated with DNase I and reverse-transcribed with
superscript reverse transcriptase (Invitrogen) using random
hexamers (Fermentas) or the specific IAV M1 primer : 59-TCT
AAC CGA GGT CGA AAC GTA-39 for virus quantification
[29,30]. PCR was performed in 20 ml reactions with specific
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GAT GAC GGA GA-39 ; antisense : 59-CTG TCT GCT GGT
GGA GTT CA-39) and IAV M1 (sense : 59-AAG ACC AAT CCT
GTC ACC TCT GA-39 ; antisense : 59-CAA AGC GTC TAC
GCT GCA GTC C-39). The mRNA levels of IFN-b and vRNA
levels of M1 were assayed using the Mastercycler realplex sequence
detector (Eppendorf) and the double strand specific dye SYBR
Green system (Applied Biosystems). The PCR conditions and cycles
were as follows: initial DNA denaturation 10 min at 95uC, followed
by 40 cycles at 95uC for 15 sec, followed by an annealing step at
64uC for 15 sec, and then extension at 72uC during 30 sec. Each
point was performed in triplicate. To ensure that the primers
produced a single and specific PCR amplification product, a
dissociation curve was performed at the end of the PCR cycle.
Relative quantitative evaluation was performed by the comparative
DDCt method. The mean DCt obtained in non stimulated cells for
eachgene was used as calibrator, after normalizationto endogenous
controlb-actin(sense:59-TGT TACCAACTGGGACGACA-39
; antisense : 59-GGG GTG TTG AAG GTC TCA AA-39). The
results are presented as an n-fold difference relative to calibrator
(RQ=22DDCt).
Microarray experiments
Separate microarrays were run for each experimental sample
(one sample per mouse and three mice per time point). Tran-
scriptional profiling was performed using Agilent’s Whole Mouse
Genome Microarray Kit, 4644 K (G4122F). Experiments were
performed at the ‘‘Plateau d’Instrumentation et de Compe ´tences
en Transcriptomique’’ (PiCT), INRA Jouy-en-Josas research
center. Minimum Information about Microarray Experiment
(MIAME) was deposited in ArrayExpress at EMBL (http://
www.ebi.ac.uk/microarray-as/ae). A dual color, balanced design
was used to provide two direct comparisons: [uninfected/infected-
by-wt-virus] and [uninfected/infected-by-DF2-virus]. Arrays were
hybridized according to the manufacturer’s instructions and as
previously described [14]. For functional analysis the data files
resulting from differential analysis were imported into GeneSpring
GX 11 software (Agilent Technologies, Massy, France). Hierar-
chical clustering analysis was performed to analyze cellular genes
that were differentially expressed during infection (Euclidian
distance, average linkage). For further analysis, data files were
uploaded into the Ingenuity Pathways Analysis (IPA) software
(Ingenuity Systems, Redwood City, CA; www.ingenuity.com).
Right-tailed Fisher’s exact test was used to calculate a p-value
determining the probability that each biological function and
disease assigned to that data set is due to chance alone.
ELISA
IL-6, TNF-a, IFN-c and CXCL1/KC concentrations in mice
BAL were determined using DuoSet ELISA kits obtained from
R&D Systems (Minneapolis, Minnesota, United States).
Apoptosis quantification
Apoptosis quantification in cells present in the BAL fluids was
performed using the ApoGlow Assay Kit (Lonza) according to the
manufacturer’s procedures. The assay is based on the biolumi-
nescent measurement of Adenylate Nucleotide Ratio (ADP/ATP).
In vivo Luminescence measurements
Recombinant replication-deficient adenovirus (purchased from
‘‘Gene Transfer Vector Core’’, University of Iowa) was used to
transduce NF-kB-luciferase (Ad-NF-kB-luc) construct in the lung
of mice. Ad-NF-kB-luc was prepared as previously described [15].
Mice received intranasal instillations of Ad-NF-kB-luc (2.56
10
8 PFU). Photon emission of the luminescent construct trans-
ducted in the lungs of mock-infected, wt- and DF2-IAV-infected
mice (1.5610
5 PFU per mouse) was measured using the IVIS
system (Xenogen Biosciences). A digital false-color photon emis-
sion image of the mouse was generated, and photons were counted
within a constant defined area corresponding to the surface of the
chest encompassing the whole lung region. Photon emission was
measured as photons emitted per second.
Immunolocalization
Paraformaldehyde-fixed cryosections were permeabilized by
0.1% Triton X-100. Endogenous peroxidase activity was inhibited
with 3% H2O2 and nonspecific sites were blocked for 1 hr with 2%
bovine serum albumin. Sections were incubated with the relevant
primary antibody (goat IgG anti-mMPO R&D Systems, goat anti-
NS1, santa cruz biotechnology) for two hours at room temperature
and with fluorochrome-conjugated secondary antibodies (bovine
anti-IgG goat Cy5, rabbit anti-IgG goat Cy3, Jakson Immuno
Research Laboratories) for 1 hr at room temperature. Nuclei were
counterstained with DAPI. Double stainings were performed by
mixing the primary antibodies and mixing fluorochrome-conjugat-
ed reagents, respectively. Quantification of fluorescence staining
was made on 6 slides from 3 different mice in each group using
Image J software.
Statistical analysis
Cytokine levels, viral loads, apoptosis measurements, lumines-
cence measurements and PMN counts are expressed as the mean
6 standard deviation (SD) of at least three separate replicates, and
statistical analyzes were performed using the unpaired Student t-
test.
Accession numbers
Entrez accession number (http://www.ncbi.nlm.nih.gov/Entrez)
of the Influenza A virus (A/WSN/1933(H1N1)) segment 2
complete sequence containing PB1-F2 ORF: CY034138. Swiss
Prot accession number (http://expasy.org/sprot) of the Influenza A
virus (A/WSN/1933(H1N1)) protein PB1-F2 : B4URF6; and PB1 :
B4URF5.
Supporting Information
Figure S1 In vivo kinetics of PB1-F2 expression in IAV-infected
mice lungs. Expressions of PB1-F2 and b-actin were monitored by
Western blot analysis (Fig1A). b-actin was used as an internal
control to standardize protein levels. Band intensities on blots were
quantified using Image J software (http://rsbweb.nih.gov/ij/).
The value for PB1-F2 are normalized against that obtained for b-
actin. Data are presented as ratio of PB1-F2/b-actin amounts and
represent the mean 6SEM values obtained from three distinct
mice.
(PDF)
Figure S2 (A) Table depicting ORF phenotypic summary of
segment 2 WSN mutants (adapted from Wise et al. J Virol. 2009.).
We used the 12 plasmids reverse genetics system to generate
recombinant viruses containing mutations on the segment 2. DF2:
the initiation and the three in-frame ATG codons of the ORF
were mutated to ACG, Stop12: a stop codon were introduced in
position 12 of ORF encoding PB1-F2. M40I and M40L mutations
destroy the N40 AUG. M40I alters the PB1-F2 sequence (W9L)
and M40L is silent in the F2 ORF.(B) Lysates from MLE-15 cells
mock-infected and infected during 24 h with the different mutant
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anti-PB1 antibody. The antibody (vC-19 purchased from Santa
Cruz Biotechnology) is directed against the C-terminal part of PB1
and is able to recognize PB1 and N40. (C) Supernatants of
infected MLE-15 cells were assayed for IFN-b secretion by ELISA.
(PDF)
Figure S3 Infectivity of WT and DF2 viruses in lungs. (A) Mice
were infected by 1.56105 PFU or mock-infected and were
sacrificed at day 2 pi. Lungs were dissected and inflated using
cryomatrix fluid. Paraformaldehyde-fixed cryosections were then
labeled with an anti-NS1 antibody (Santa Cruz Biotechnology)
and nuclei were counterstained with DAPI. (B) Quantification of
fluorescence staining was made on randomly chosen slides from 3
different mice in each group using Image J software. Infectivity of
the viruses was compared using the ratio NS1/DAPI, i.e. number
of infected cells vs.number of total cells of the sections.
(PDF)
Figure S4 Impact of PB1-F2 expression on several inflammatory
markers. Total RNA isolated from lungs of infected mice (day 2 pi)
were reverse-transcribed and used to quantify expression of several
inflammatory markers by qPCR :chemokine (C-C motif) receptor
1 (Ccr1, Gene ID: 12768), chemokine (C-X-C motif) ligand 1
(Cxcl1, Gene ID:14825), colony stimulating factor 3 (Csf3, Gene
ID: 12985), pentraxin 3 (Ptx3, Gene ID: 19288), tumor necrosis
factor alpha (Tnf-a, Gene ID: 21926) and triggering receptor
expressed on myeloid cells 1 (Trem1, Gene ID:58217). Gene
expressions were normalized with the b-actin gene expression level
and presented as fold increase relative to mock-treated mice. Data
are means 6 SD obtained from three mice. Asterisks (*) indicates
p,0.05.
(PDF)
Figure S5 Positive control of luminescence emission from
BALB/c mice intranasally instillated with 2.56108 PFU of Ad-
NF-kB-luc. Mice were anesthetized by a mixture of ketamine and
xylazine (1 and 0.2 mg per mouse, respectively) and infected
intranasally with 50 ml of PBS containing 2.56108 PFU of Ad-
NF-kB-luc. 24 hours postinhalation, mice were stimulated with
10 mg of E. coli LPS. 24 hours post-stimulation, bioluminescence
was measured by intranasal injection of 50 ml of luciferine
(500 mg/ml) and capture of photon emission from the chest using
the IVIS system. The scale indicates the average radiance: the sum
of the ph otons per second from eachpixel inside the ROI/number
of pixels (photons/sec/cm2/sr).
(PDF)
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